Bain Capital Public Equity Management, LLC - Q2 2019 holdings

$0 is the total value of Bain Capital Public Equity Management, LLC's 0 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 101.6% .

 Value Shares↓ Weighting
New00$00
+100.0%
0.00%
CRIS ExitCURIS INC$0-64,134
-100.0%
-0.01%
LLY ExitLILLY ELI & COput$0-700
-100.0%
-0.02%
NOC ExitNORTHROP GRUMMAN CORPcall$0-680
-100.0%
-0.02%
VGK ExitVANGUARD INTL EQUITY INDEX Fput$0-3,500
-100.0%
-0.03%
PTI ExitPROTEOSTASIS THERAPEUTICS IN$0-231,418
-100.0%
-0.03%
SAP ExitSAP SEcall$0-2,500
-100.0%
-0.04%
HON ExitHONEYWELL INTL INCcall$0-2,200
-100.0%
-0.05%
ExitCROWN HOLDINGS INCcall$0-5,000
-100.0%
-0.06%
ExitCOMCAST CORP NEWcall$0-10,000
-100.0%
-0.06%
XBI ExitSPDR SERIES TRUSTput$0-3,125
-100.0%
-0.06%
WYNN ExitWYNN RESORTS LTDcall$0-2,570
-100.0%
-0.12%
ATI ExitALLEGHENY TECHNOLOGIES INC$0-66,649
-100.0%
-0.16%
EBSB ExitMERIDIAN BANCORP INC MD$0-112,252
-100.0%
-0.17%
ExitFORTIVE CORPORATION 0.875 02/15/2022convertible bond - private placement$0-1,950,000
-100.0%
-0.20%
CTXS ExitCITRIX SYS INCcall$0-10,005
-100.0%
-0.22%
ExitNOVARTIS A Gcall$0-8,312
-100.0%
-0.22%
RH ExitRH$0-23,866
-100.0%
-0.23%
SPY ExitSPDR S&P 500 ETF TRput$0-5,820
-100.0%
-0.24%
IWM ExitISHARES TRput$0-8,622
-100.0%
-0.26%
SAIC ExitSCIENCE APPLICATNS INTL CP N$0-48,589
-100.0%
-0.36%
TBIO ExitTRANSLATE BIO INC$0-416,670
-100.0%
-0.40%
GSK ExitGLAXOSMITHKLINE PLCsponsored adr$0-103,036
-100.0%
-0.41%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-84,501
-100.0%
-0.42%
PLCE ExitCHILDRENS PL INC$0-44,906
-100.0%
-0.42%
CRM ExitSALESFORCE COM INC$0-31,664
-100.0%
-0.48%
LYFT ExitLYFT INC$0-70,000
-100.0%
-0.52%
IRWD ExitIRONWOOD PHARMACEUTICALS INC$0-407,598
-100.0%
-0.53%
JCI ExitJOHNSON CTLS INTL PLC$0-160,661
-100.0%
-0.57%
SWK ExitSTANLEY BLACK & DECKER INC$0-45,347
-100.0%
-0.59%
AFMD ExitAFFIMED N V$0-1,506,595
-100.0%
-0.60%
PFPT ExitPROOFPOINT INC$0-57,069
-100.0%
-0.66%
CLDR ExitCLOUDERA INC$0-686,813
-100.0%
-0.72%
DVAX ExitDYNAVAX TECHNOLOGIES CORP$0-1,262,328
-100.0%
-0.88%
GBT ExitGLOBAL BLOOD THERAPEUTICS IN$0-175,333
-100.0%
-0.89%
HOME ExitAT HOME GROUP INC$0-533,603
-100.0%
-0.91%
GSAHU ExitGS ACQUISITION HLDGS CORPunit 06/12/2023$0-1,000,000
-100.0%
-1.00%
ETFC ExitE TRADE FINANCIAL CORP$0-265,475
-100.0%
-1.18%
NVO ExitNOVO-NORDISK A Sadr$0-251,882
-100.0%
-1.26%
CSX ExitCSX CORP$0-188,061
-100.0%
-1.34%
AABA ExitALTABA INC$0-219,439
-100.0%
-1.55%
CDAY ExitCERIDIAN HCM HLDG INC$0-321,084
-100.0%
-1.57%
GD ExitGENERAL DYNAMICS CORP$0-104,561
-100.0%
-1.69%
IQV ExitIQVIA HOLDINGS INC$0-123,954
-100.0%
-1.70%
AZO ExitAUTOZONE INC$0-17,958
-100.0%
-1.76%
SYF ExitSYNCHRONY FINL$0-638,311
-100.0%
-1.94%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-113,174
-100.0%
-1.97%
GOOGL ExitALPHABET INCcap stk cl a$0-17,561
-100.0%
-1.97%
CMCSA ExitCOMCAST CORP NEWcl a$0-614,477
-100.0%
-2.34%
ExitCITRIX SYS INC$0-248,857
-100.0%
-2.37%
ELAN ExitELANCO ANIMAL HEALTH INC$0-836,601
-100.0%
-2.56%
WEX ExitWEX INC$0-143,327
-100.0%
-2.63%
BLL ExitBALL CORP$0-590,427
-100.0%
-3.26%
VOYA ExitVOYA FINL INC$0-705,860
-100.0%
-3.36%
ExitWYNN RESORTS LTD$0-304,020
-100.0%
-3.46%
ExitNORTHROP GRUMMAN CORP$0-162,518
-100.0%
-4.18%
HON ExitHONEYWELL INTL INC$0-276,757
-100.0%
-4.20%
GDDY ExitGODADDY INCcl a$0-788,165
-100.0%
-5.66%
PLAN ExitANAPLAN INC$0-1,549,427
-100.0%
-5.82%
CCK ExitCROWN HOLDINGS INC$0-1,250,773
-100.0%
-6.51%
NVS ExitNOVARTIS A Gsponsored adr$0-882,000
-100.0%
-8.09%
DOCU ExitDOCUSIGN INC$0-3,051,166
-100.0%
-15.09%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CITRIX SYS INC18Q3 20186.7%
QUINTILES TRANSNATIO HLDGS I18Q3 20173.5%
AFFIMED N V16Q1 20191.0%
BALL CORP13Q1 20197.2%
RADIUS HEALTH INC13Q2 20178.4%
TRANSDIGM GROUP INC11Q2 201610.1%
ULTA SALON COSMETCS & FRAG I11Q4 20155.4%
VIASAT INC11Q2 20177.5%
AETNA INC NEW11Q2 20174.1%
GODADDY INC10Q1 20195.7%

View Bain Capital Public Equity Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Bain Capital Public Equity Management, LLC Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Affimed N.V.February 14, 20192,362,8133.8%
IMMUNE DESIGN CORP.February 14, 2019892,0611.8%
REVA Medical, Inc.February 14, 2019296,502,2207.2%
MULESOFT, INCFebruary 14, 20181,404,0251.9%
CONCERT PHARMACEUTICALS, INC.February 28, 20141,147,8336.7%
IDENIX PHARMACEUTICALS INCFebruary 12, 201413,115,8589.8%
NORTHSTAR REALTY FINANCE CORP.February 12, 20147,657,7812.6%
PORTOLA PHARMACEUTICALS INCFebruary 12, 2014400,0001.0%
Dicerna Pharmaceuticals IncFebruary 10, 20141,337,0008.0%
RingCentral IncFebruary 07, 2014471,0735.5%

View Bain Capital Public Equity Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
SC 13G/A2019-02-14
SC 13G/A2019-02-14

View Bain Capital Public Equity Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported number of holdings is incorrect (0 != 1)

Export Bain Capital Public Equity Management, LLC's holdings